Citius Oncology, Inc.(CTOR)

Medical - Pharmaceuticals · Cranford, NY

$0.87-0.00 (-0.24%)

Delayed quote: Oct 6, 2026, 10:52 AM EDT

Earnings Yield: N/A

Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The earnings yield is N/A as of 2026-10-06T14:56:29.692Z.

Stored calculation inputs

Calculation as of: 2026-10-06T14:56:29.692Z.

Quote observation: 2026-10-06T14:52:50.000Z. Amounts in USD. The price header may show a later quote.

Unrounded diluted TTM EPS · period ending 2026-06-30: -0.4777
Quote price: 0.8714

FMP input reference: e47236677832b0178bb4e4de0ecbdefb2e069a6eb9feaf5a3a870b06349bdf9c

P/E Ratio|FCF Yield|Dividend Yield|All Metrics

CTOR Earnings Yield Metrics

EARNINGS YIELD

N/A

CTOR Competitors' Earnings Yield

CTOR

Citius Oncology, Inc.

Current

Market Cap

$81.02M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

LNSR

LENSAR Inc

vs CTOR

Market Cap

$81.92M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ACRV

Acrivon Therapeutics, Inc. Common Stock

vs CTOR

Market Cap

$82.82M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MNOV

MediciNova, Inc.

vs CTOR

Market Cap

$82.64M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

LUNG

Pulmonx Corporation

vs CTOR

Market Cap

$79.68M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

HUMA

Humacyte, Inc.

vs CTOR

Market Cap

$84.35M

Earnings Yield

N/A

TTM Avg

12.67%

3Y Avg

12.67%

5Y Avg

12.67%

NTRB

Nutriband Inc.

vs CTOR

Market Cap

$84.85M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CGTX

Cognition Therapeutics, Inc.

vs CTOR

Market Cap

$84.58M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CRDF

Cardiff Oncology, Inc.

vs CTOR

Market Cap

$85.17M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Outset Medical, Inc.

vs CTOR

Market Cap

$78.23M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EARNINGS YIELD	TTM	3Y	5Y
Citius Oncology, Inc. (CTOR)	$81.02M	N/A	N/A	N/A	N/A
LENSAR Inc (LNSR)vs ›	$81.92M	N/A	N/A	N/A	N/A
Acrivon Therapeutics, Inc. Common Stock (ACRV)vs ›	$82.82M	N/A	N/A	N/A	N/A
MediciNova, Inc. (MNOV)vs ›	$82.64M	N/A	N/A	N/A	N/A
Pulmonx Corporation (LUNG)vs ›	$79.68M	N/A	N/A	N/A	N/A
Humacyte, Inc. (HUMA)vs ›	$84.35M	N/A	12.67%	12.67%	12.67%
Nutriband Inc. (NTRB)vs ›	$84.85M	N/A	N/A	N/A	N/A
Cognition Therapeutics, Inc. (CGTX)vs ›	$84.58M	N/A	N/A	N/A	N/A
Cardiff Oncology, Inc. (CRDF)vs ›	$85.17M	N/A	N/A	N/A	N/A
Outset Medical, Inc. (OM)vs ›	$78.23M	N/A	N/A	N/A	N/A

Earnings Yield vs P/E Ratio

Earnings Yield

N/A

EPS ÷ Price

P/E Ratio

N/A

Price ÷ EPS

Formula: Earnings Yield = (EPS / Price) × 100

Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.

How earnings yield is used:

It expresses earnings relative to share price as a percentage
It can be compared with FCF yield and dividend yield
It can be compared with bond yields because both are percentages
It is mathematically the inverse of the P/E ratio

Earnings Yield Formula & Definition

Earnings Yield = EPS (TTM) / Share Price

Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Earnings Yield: N/A

CTOR Earnings Yield Metrics

CTOR Competitors' Earnings Yield

Earnings Yield vs P/E Ratio

Earnings Yield Formula & Definition

Related Metrics